Industrial conglomerate 3M Co is exploring a sale of its drug delivery systems unit, which could fetch around $1 billion, Bloomberg reported on Friday, citing people with knowledge of the matter. The company is currently working with an adviser to run an auction process for the business, Bloomberg reported, adding that the business is likely to draw interest from private equity firms. 3M’s drug delivery business, which manufacturers inhalers and skin patches, accounted for about 1.4% of the company’s 2018 revenue of $32.77 billion. …read more
Source:: Yahoo Finance
